Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Fundación Española de Hematología y Hemoterapía
Hospital Italiano de Buenos Aires
Centre Hospitalier Universitaire de Liege
xCures
New York Medical College
Shenzhen Geno-Immune Medical Institute
National Institutes of Health Clinical Center (CC)
Office of Rare Diseases (ORD)